Individual differences in physical symptom burden and psychological responses in individuals with chronic lymphocytic leukemia

Morrison, Eleshia; Flynn, Joseph; Jones, Jeffrey; Byrd, John; Andersen, Barbara; Morrison, Eleshia J; Flynn, Joseph M; Byrd, John C; Andersen, Barbara L
December 2016
Annals of Hematology;Dec2016, Vol. 95 Issue 12, p1989
Academic Journal
journal article
Chronic lymphocytic leukemia (CLL) is an incurable illness, with some patients requiring no treatment until disease progression. Burden from physical symptoms has been associated with depression, anxiety, and stress in cancer patients. Additionally, patient factors, i.e., individual differences, have been associated with worse psychological outcomes. There are few psychological studies of CLL, with no examination of individual differences. A cross-sectional design studied the covariation of symptom burden with depressive and anxiety symptoms and cancer-specific stress, and tested patients' individual differences as predictors and as moderators. CLL patients (N = 112) receiving active surveillance participated. They were Caucasian (100 %) and predominately male (55 %) with a mean age of 61; most (62.5 %) had stage 0 disease. A composite measure of physical symptom burden (CLL symptoms, fatigue, pain, impaired functional status) was tested as a predictor of psychological responses. Individual differences in psychiatric history and social support were tested as moderators. Using multiple linear regression, greater symptom burden covaried with higher levels of depressive and anxiety symptoms and cancer stress (ps < .05). Those with a psychiatric history, low social support, and low relationship satisfaction with one's partner reported greater symptom burden and more psychological symptoms and stress (ps < .05). Findings suggest that CLL patients in surveillance with a psychiatric history and/or low social support are at risk for greater distress when coping with high symptom burden. These new data clarify the experience of CLL surveillance and identify characteristics of patients with heightened risk for symptom burden, stress, and anxiety or depressive symptoms.


Related Articles

  • Chronic Lymphocytic Leukemia. From Diagnosis to Treatment Decision. Ivanescu, Ana-Maria; Oprea, Madalina; Colita, A.; Turbatu, A.; Lupu, Anca Roxana // Medicina Moderna;2014, Vol. 21 Issue 4, p304 

    Chronic lymphocytic leukemia is an indolent chronic lymphoproliferation with a highly heterogeneous evolution often burdened by difficult unmanageable relapses. Complete clinical and laboratory investigations since the debut contribute significantly to choosing the most appropriate therapeutic...

  • An unusual presentation of chronic lymphocytic leukemia. Atwal, Dinesh; Raval, Mihir; Firwana, Belal; Ramos, Jeanette; Sasapu, Appalanaidu // Avicenna Journal of Medicine;Jul-Sep2017, Vol. 7 Issue 3, p133 

    Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a B‑cell lymphocytic neoplasm with indolent clinical course. If identified early, observation is opted. Many variables lead to the initiation of treatment. Authors describe a 62‑year‑old male presenting...

  • Familial Lymphoproliferative Malignancy: Clinical and Laboratory Follow-Up. Blattner, William A.; Dean, Jack H.; Fraumeni, Joseph F. // Annals of Internal Medicine;Jun79, Vol. 90 Issue 6, p943 

    Focuses on the aggregation of chronic lymphocytic leukemia in three siblings. Medical history of the patients; Diagnosis and treatment; Information on chronic lymphocytic leukemia.

  • New Directions in the Diagnosis and Treatment of Chronic Lymphocytic Leukaemia. Schriever, Folke; Huhn, Dieter // Drugs;2003, Vol. 63 Issue 10, p953 

    Chronic lymphocytic leukaemia (CLL) is the most common leukaemia of adults in Western countries. It is a systemic haematological malignancy that originates from B cells (B-CLL) in 95% of patients, while only a minority are derived through malignant transformation of T cells (T-CLL). Although...

  • When prognosis is poor, does false hope add to leukemia patients' pain? Miller, Mike; Miller, M // JNCI: Journal of the National Cancer Institute;08/19/98, Vol. 90 Issue 16, p1192 

    Focuses on the treatment advice which doctors should be offering patients who are in the later stages of chronic lymphocytic leukemia (CLL) that have a poor prognosis. Report published in the June 3, 1998 `Journal of the American Medical Association'; Definition of the CLL disease; Changes an...

  • Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids Syndrome: Diagnostic Challenge of the Brainstem Inflammation. Bladowska, Joanna; Waliszewska-Prosół, Marta; Rojek, agata; Obara, Krystian; Pokryszko-Dragan, anna; Podemski, Ryszard // European Neurology;Jan2017, Vol. 77 Issue 1/2, p103 

    The article presents a case study of a 57-year-old man with history of progressive cerebellar-pyramidal syndrome and mention how changes of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids, create a diagnostic challenge of the brainstem inflammation.

  • Array-based karyotyping in chronic lymphocytic leukemia (CLL) detects new unbalanced abnormalities that escape conventional cytogenetics and CLL FISH. Urbankova, Helena; Papajik, Tomas; Plachy, Radek; Holzerova, Milena; Balcarkova, Jana; Divoka, Martina; Prochazka, Vit; Pikalova, Zuzana; Indrak, Karel; Jarosova, Marie // Biomedical Papers of the Medical Faculty of Palacky University i;Mar2014, Vol. 158 Issue 1, p56 

    Aims. Chronic lymphocytic leukemia (CLL) is the most common adult leukemia with a very heterogeneous course. Progress in molecular genetic characterization of CLL has confirmed the prognostic role of unbalanced chromosomal abnormalities currently defined by molecular cytogenetic methods:...

  • CME. Chronic lymphocytic leukemia: The most common leukemia in adults. Washburn, Leslie // JAAPA: Journal of the American Academy of Physician Assistants (;May2011, Vol. 24 Issue 5, p54 

    The article offers information on related to incidence, diagnosis, and complications of chronic lymphocytic leukemia (CLL), considered as the most common type leukemia in adults. It mentions that the diagnosis of CLL to an individual requires the existence of at least 5,000 B lymphocytes per...

  • Prognostic Importance of Serum Light Chains in Patients with CLL.  // Clinical Oncology Alert;Feb2012, Vol. 28 Issue 2, p10 

    The author discusses a study by F. Morabito and colleagues, which shows that determination of serum light chain ratio is useful for the initial evaluation of chronic lymphocytic leukemia (CLL) patients. He mentions that an abnormal k/l ratio indicates clonality and offers prognostic information...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics